Personalized mRNA Vaccine Shows Promise in Extending Pancreatic Cancer Survival
April 22, 2026 — Early trial shows personalized mRNA vaccine extends survival in pancreatic cancer patients. TinyGems reports on breakthrough findings presented at oncology conference, with companies like Calidi Biotherapeutics exploring similar approaches.